Evaluation of plasma brain-derived neurotrophic factor levels and self-perceived cognitive impairment post-chemotherapy: a longitudinal study

BACKGROUND: Preliminary evidence suggests that changes in plasma brain-derived neurotrophic factor (BDNF) levels may contribute to the occurrence of chemotherapy-associated cognitive impairment (CACI), and a previous study suggested that carriers of the BDNF Met homozygous genotype are protected fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Terence, Lee, Ying Yun, Chae, Jung-woo, Yeo, Angie Hui Ling, Shwe, Maung, Gan, Yan Xiang, Ng, Raymond C. H., Chu, Pat Pak Yan, Khor, Chiea Chuen, Ho, Han Kiat, Chan, Alexandre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735945/
https://www.ncbi.nlm.nih.gov/pubmed/29258453
http://dx.doi.org/10.1186/s12885-017-3861-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735945/
https://www.ncbi.nlm.nih.gov/pubmed/29258453
http://dx.doi.org/10.1186/s12885-017-3861-9

Ejemplares similares